In 2018, the AACR reported another year of positive operating returns. This financial stability enables the AACR to comprehensively meet the challenges of the cancer problem. Operating revenues totaled $111.5 million and total expenditures closely matched revenues. The net impact of revenues and expenses resulted in an operating surplus of $1.4 million. As outlined in this report, several major projects were launched in 2018, and the AACR was able to outperform the budget through successful programming, revenue growth, and prudent financial management.

Non-operating activities are primarily related to long-term investments. After several years of positive performance in the AACR’s investment portfolio, the portfolio experienced negative returns in the amount of $5.8 million in 2018 due to a market correction. These returns were offset in part by the net operating surplus, resulting in an overall net deficit of $4.4 million for the year. Fortunately, the AACR was able to manage its operating budget without using investment income, so the negative market returns did not have an adverse effect on net operating income.

As a result of the financial performance for the year 2018, the AACR’s unrestricted net assets are now $71.8 million. These reserves ensure continued investment in the programs and initiatives that support the AACR’s mission to prevent and cure all cancers.

2018 TOTAL EXPENSES

2018 PROGRAM EXPENSES